DK0723453T3 - Fremgangsmåde til behandling af reproduktionssygdomme - Google Patents
Fremgangsmåde til behandling af reproduktionssygdommeInfo
- Publication number
- DK0723453T3 DK0723453T3 DK94926472T DK94926472T DK0723453T3 DK 0723453 T3 DK0723453 T3 DK 0723453T3 DK 94926472 T DK94926472 T DK 94926472T DK 94926472 T DK94926472 T DK 94926472T DK 0723453 T3 DK0723453 T3 DK 0723453T3
- Authority
- DK
- Denmark
- Prior art keywords
- treating reproductive
- reproductive diseases
- insulin
- growth factor
- treating
- Prior art date
Links
- 208000017443 reproductive system disease Diseases 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 abstract 2
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 abstract 2
- 102000013275 Somatomedins Human genes 0.000 abstract 2
- 230000035800 maturation Effects 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
- Surgical Instruments (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10125593A | 1993-08-03 | 1993-08-03 | |
| PCT/US1994/008627 WO1995003817A1 (fr) | 1993-08-03 | 1994-08-02 | Procede de traitement de dysfonctionnements de la reproduction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0723453T3 true DK0723453T3 (da) | 2000-06-05 |
Family
ID=22283716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94926472T DK0723453T3 (da) | 1993-08-03 | 1994-08-02 | Fremgangsmåde til behandling af reproduktionssygdomme |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0723453B1 (fr) |
| JP (1) | JPH09503753A (fr) |
| AT (1) | ATE190499T1 (fr) |
| AU (1) | AU674449B2 (fr) |
| CA (1) | CA2168790A1 (fr) |
| DE (1) | DE69423506T2 (fr) |
| DK (1) | DK0723453T3 (fr) |
| ES (1) | ES2144527T3 (fr) |
| GR (1) | GR3033523T3 (fr) |
| PT (1) | PT723453E (fr) |
| WO (1) | WO1995003817A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015786A (en) * | 1997-02-25 | 2000-01-18 | Celtrix Pharmaceuticals, Inc. | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
| US6514937B1 (en) * | 1997-02-25 | 2003-02-04 | Celtrix Pharmaceuticals, Inc. | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| US6025368A (en) * | 1997-02-25 | 2000-02-15 | Celtrix Pharmaceuticals, Inc. | Method for treating the symptoms of chronic stress-related disorders using IGF |
| US6417330B1 (en) | 1998-06-01 | 2002-07-09 | Celtrix Pharmaceuticals, Inc. | Insulin-like growth factor binding protein variants |
| US7288516B1 (en) | 1999-09-20 | 2007-10-30 | Celtrix Pharmaceuticals, Inc. | Null IGF for the treatment of cancer |
| US6040292A (en) * | 1999-06-04 | 2000-03-21 | Celtrix Pharmaceuticals, Inc. | Methods for treating diabetes |
| US20030035788A1 (en) | 2000-09-19 | 2003-02-20 | Desmond Mascarenhas | Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
| US6914049B2 (en) | 2001-09-18 | 2005-07-05 | Bioexpertise, Llc | IGF-binding protein-derived peptide or small molecule |
| US6887851B2 (en) | 2001-09-18 | 2005-05-03 | Bioexpertise, Llc | IGF-binding protein-derived peptide |
| EP1435986B1 (fr) | 2001-09-18 | 2008-01-02 | Bioexpertise, Llc | Peptide derive de proteines de liaison de l'igf |
| EP1483368A2 (fr) | 2002-03-08 | 2004-12-08 | McGill University | Maturation in vitro d'ovocytes humains immatures |
| PL1828225T3 (pl) | 2004-12-24 | 2011-03-31 | Insmed Inc | Oczyszczone kompleksy rhIGF-I/rhIGFBP-3 i sposób ich wytwarzania |
| EP3055408A4 (fr) * | 2013-10-07 | 2017-06-14 | Northeastern University | Procédés et compositions pour la production ex vivo d' ufs compétents au point de vue du développement à partir de cellules de lignée germinale au moyen de systèmes cellulaires autologues |
| CN107073036A (zh) | 2014-03-27 | 2017-08-18 | 东北大学 | 用于卵巢卵泡生长和成熟的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK131988A (da) * | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
-
1994
- 1994-08-02 JP JP7506016A patent/JPH09503753A/ja active Pending
- 1994-08-02 CA CA002168790A patent/CA2168790A1/fr not_active Abandoned
- 1994-08-02 AT AT94926472T patent/ATE190499T1/de not_active IP Right Cessation
- 1994-08-02 PT PT94926472T patent/PT723453E/pt unknown
- 1994-08-02 ES ES94926472T patent/ES2144527T3/es not_active Expired - Lifetime
- 1994-08-02 DE DE69423506T patent/DE69423506T2/de not_active Expired - Fee Related
- 1994-08-02 AU AU76297/94A patent/AU674449B2/en not_active Ceased
- 1994-08-02 EP EP94926472A patent/EP0723453B1/fr not_active Expired - Lifetime
- 1994-08-02 WO PCT/US1994/008627 patent/WO1995003817A1/fr active IP Right Grant
- 1994-08-02 DK DK94926472T patent/DK0723453T3/da active
-
2000
- 2000-05-26 GR GR20000401214T patent/GR3033523T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69423506D1 (de) | 2000-04-20 |
| ES2144527T3 (es) | 2000-06-16 |
| GR3033523T3 (en) | 2000-09-29 |
| AU674449B2 (en) | 1996-12-19 |
| CA2168790A1 (fr) | 1995-02-09 |
| DE69423506T2 (de) | 2000-09-21 |
| ATE190499T1 (de) | 2000-04-15 |
| AU7629794A (en) | 1995-02-28 |
| EP0723453A1 (fr) | 1996-07-31 |
| EP0723453B1 (fr) | 2000-03-15 |
| EP0723453A4 (fr) | 1997-01-29 |
| JPH09503753A (ja) | 1997-04-15 |
| PT723453E (pt) | 2000-07-31 |
| WO1995003817A1 (fr) | 1995-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0723453T3 (da) | Fremgangsmåde til behandling af reproduktionssygdomme | |
| DK0436469T3 (da) | Præparat og fremgangsmåde til behandling af osteoporose i pattedyr | |
| MY124311A (en) | Parathyroid hormone and raloxifene for increasing bone mass | |
| DE69219607D1 (de) | Verfahren zur anregung der immunresponz | |
| FI93460B (fi) | Menetelmä uusien insuliinijohdannaisten valmistamiseksi | |
| FI971420A (fi) | Menetelmä diabetes mellituksen hoitamiseksi KGF:ää käyttämällä | |
| EP0607775A3 (fr) | ||
| GR3004103T3 (fr) | ||
| DK0661990T3 (da) | Fremgangsmåde til systemisk behandling af kataboliske tilstande og systemisk vævsbeskadigelse | |
| DE69324046D1 (de) | Protein präparate zur verhütung und behandlung van periodontitis und sonstigen bakteriellen erkrankungen der mundhöhle | |
| DE69232561D1 (de) | Verfahren zur erhöhung der darmabsorption | |
| WO1994010207A3 (fr) | Proteines tronquees de liaison au facteur de croissance insulinoide a activite mitogene | |
| ATE271879T1 (de) | Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen | |
| GB9410639D0 (en) | Method of improving fertilization | |
| SE9402331D0 (sv) | New use | |
| ATE45675T1 (de) | Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen. | |
| ATE153859T1 (de) | Somatotropin zur erhoehung der reproduktiven leistung in rinder | |
| SE8501202L (sv) | Humant intestinalt hormon och deras anvendning | |
| DK1135154T3 (da) | Forbedring af follikulogenese | |
| SE9303784D0 (sv) | Igf | |
| DE69006032D1 (de) | Verfahren zur behandlung von unfruchtbarkeit oder verminderter fruchtbarkeit bei erwachsenen männern und die verwendung von präparaten in diesem verfahren. | |
| AU1786988A (en) | Isoxazoles with nootropic activity | |
| DE3479477D1 (en) | A pharmaceutical composition for use in treating neurological disease or aging | |
| DE3786442D1 (de) | Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung. |